Adverse Event Reporting in Clinical Trials: Time to Include Duration as Well as Severity von Sartor, Oliver

Volltext

Metastatic castration‐sensitive prostate cancer: Abiraterone, docetaxel, or von Barata, Pedro C., Sartor, A. Oliver

Volltext

Olaparib for Metastatic Castration-Resistant Prostate Cancer von de Bono, Johann, Mateo, Joaquin, Fizazi, Karim, Saad, Fred, Shore, Neal, Sandhu, Shahneen, Chi, Kim N, Sartor, Oliver, Agarwal, Neeraj, Olmos, David, Thiery-Vuillemin, Antoine, Twardowski, Przemyslaw, Mehra, Niven, Goessl, Carsten, Kang, Jinyu, Burgents, Joseph, Wu, Wenting, Kohlmann, Alexander, Adelman, Carrie A, Hussain, Maha

Volltext

Prostate cancer – major changes in the American Joint Committee on Cancer eighth edition cancer staging manual von Buyyounouski, Mark K., Choyke, Peter L., McKenney, Jesse K., Sartor, Oliver, Sandler, Howard M., Amin, Mahul B., Kattan, Michael W., Lin, Daniel W.

Volltext

Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial von de Bono, Johann Sebastian, Dr, Oudard, Stephane, MD, Ozguroglu, Mustafa, MD, Hansen, Steinbjørn, MD, Machiels, Jean-Pascal, MD, Kocak, Ivo, MD, Gravis, Gwenaëlle, MD, Bodrogi, Istvan, MD, Mackenzie, Mary J, MD, Shen, Liji, PhD, Roessner, Martin, MS, Gupta, Sunil, MD, Sartor, A Oliver, MD

Volltext

Navigating the evolving therapeutic landscape in advanced prostate cancer von Crawford, E. David, M.D, Petrylak, Daniel, M.D, Sartor, Oliver, M.D

Volltext

Status of PSMA-targeted radioligand therapy in prostate cancer: current data and future trials von Jang, Albert, Kendi, Ayse T., Sartor, Oliver

Volltext

Germline BLM mutations and metastatic prostate cancer von Ledet, Elisa M., Antonarakis, Emmanuel S., Isaacs, William B., Lotan, Tamara L., Pritchard, Colin, Sartor, A. Oliver

Volltext

Targeted Alpha-Particle Therapy: A Review of Current Trials von Jang, Albert, Kendi, Ayse T, Johnson, Geoffrey B, Halfdanarson, Thorvardur R, Sartor, Oliver

Volltext

Efficacy and safety of radium-223 dichloride in patients with castration-resistant prostate cancer and symptomatic bone metastases, with or without previous docetaxel use: a prespe... von Hoskin, Peter, Prof, Sartor, Oliver, Prof, O'Sullivan, Joe M, Prof, Johannessen, Dag Clement, MD, Helle, Svein I, MD, Logue, John, FRCR, Bottomley, David, FRCR, Nilsson, Sten, Prof, Vogelzang, Nicholas J, Prof, Fang, Fang, PhD, Wahba, Mona, MD, Aksnes, Anne-Kirsti, PhD, Parker, Christopher, MD

Volltext

Real‐world outcomes of sipuleucel‐T treatment in PROCEED, a prospective registry of men with metastatic castration‐resistant prostate cancer von Higano, Celestia S., Armstrong, Andrew J., Sartor, A. Oliver, Vogelzang, Nicholas J., Kantoff, Philip W., McLeod, David G., Pieczonka, Christopher M., Penson, David F., Shore, Neal D., Vacirca, Jeffrey, Concepcion, Raoul S., Tutrone, Ronald F., Nordquist, Luke T., Quinn, David I., Kassabian, Vahan, Scholz, Mark C., Harmon, Matt, Tyler, Robert C., Chang, Nancy N., Tang, Hong, Cooperberg, Matthew R.

Volltext

Androgen Receptor Splice Variants Dimerize to Transactivate Target Genes von Xu, Duo, Zhan, Yang, Qi, Yanfeng, Cao, Bo, Bai, Shanshan, Xu, Wei, Gambhir, Sanjiv S, Lee, Peng, Sartor, Oliver, Flemington, Erik K, Zhang, Haitao, Hu, Chang-Deng, Dong, Yan

Volltext

Prostate specific membrane antigen binding radiopharmaceuticals: Current data and new concepts von Sartor, Oliver, Baghian, Ali

Volltext

Effect of radium-223 dichloride on symptomatic skeletal events in patients with castration-resistant prostate cancer and bone metastases: results from a phase 3, double-blind, rand... von Sartor, Oliver, Prof, Coleman, Robert, Prof, Nilsson, Sten, Prof, Heinrich, Daniel, MD, Helle, Svein I, MD, O'Sullivan, Joe M, Prof, Fosså, Sophie D, Prof, Chodacki, Aleš, MD, Wiechno, Paweł, MD, Logue, John, FRCR, Widmark, Anders, Prof, Johannessen, Dag Clement, MD, Hoskin, Peter, Prof, James, Nicholas D, Prof, Solberg, Arne, MD, Syndikus, Isabel, FRCR, Vogelzang, Nicholas J, Prof, O'Bryan-Tear, C Gillies, MRCP, Shan, Minghua, PhD, Bruland, Øyvind S, Prof, Parker, Christopher, MD

Volltext

Adjuvant and Salvage Radiation Therapy After Prostatectomy: American Society for Radiation Oncology/American Urological Association Guidelines von Valicenti, Richard K., MD, MBA, Thompson, Ian, MD, Albertsen, Peter, MD, MS, Davis, Brian J., MD, PhD, Goldenberg, S. Larry, MD, Wolf, J. Stuart, MD, Sartor, Oliver, MD, Klein, Eric, MD, Hahn, Carol, MD, Michalski, Jeff, MD, MBA, Roach, Mack, MD, Faraday, Martha M., PhD

Volltext

The 1.5°C target and coal sector transition: at the limits of societal feasibility von Spencer, Thomas, Colombier, Michel, Sartor, Oliver, Garg, Amit, Tiwari, Vineet, Burton, Jesse, Caetano, Tara, Green, Fergus, Teng, Fei, Wiseman, John

Volltext

Treatment sequencing in metastatic castrate-resistant prostate cancer von Sartor, Oliver, Gillessen, Silke

Volltext

PSMA ADC monotherapy in patients with progressive metastatic castration‐resistant prostate cancer following abiraterone and/or enzalutamide: Efficacy and safety in open‐label singl... von Petrylak, Daniel P., Vogelzang, Nicholas J., Chatta, Kamal, Fleming, Mark T., Smith, David C., Appleman, Leonard J., Hussain, Arif, Modiano, Manuel, Singh, Parminder, Tagawa, Scott T., Gore, Ira, McClay, Edward F., Mega, Anthony E., Sartor, A. Oliver, Somer, Bradley, Wadlow, Raymond, Shore, Neal D., Olson, William C., Stambler, Nancy, DiPippo, Vincent A., Israel, Robert J.

Volltext

Alkaline phosphatase in metastatic castration-resistant prostate cancer: reassessment of an older biomarker von Heinrich, Daniel, Bruland, Øyvind, Guise, Theresa A, Suzuki, Hiroyoshi, Sartor, Oliver

Volltext

Biomarkers in the Management and Treatment of Men with Metastatic Castration-Resistant Prostate Cancer von Armstrong, Andrew J, Eisenberger, Mario A, Halabi, Susan, Oudard, Stephane, Nanus, David M, Petrylak, Daniel P, Sartor, A. Oliver, Scher, Howard I

Volltext